Closed-Chest Microdialysis to Measure Antibiotic Penetration into Human Lung Tissue
- 15 January 2002
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 165 (2) , 273-276
- https://doi.org/10.1164/ajrccm.165.2.2106082
Abstract
The majority of bacterial lung infections are localized to the interstitial space fluid, which is therefore an important target site for antimicrobial chemotherapy. Direct measurement of interstitial concentrations of antimicrobial agents in human lung tissue would allow for a more informed approach to appropriate dosing of antimicrobial agents, but until now this was beyond technical reach. In this exploratory pharmacokinetic study, we measured the time versus concentration profile of cefpirome after a single intravenous dose administration of 2 g in the lung interstitial fluid by flexible microdialysis catheters, which were implanted during lung surgery for pulmonary tumors in five patients. Cefpirome concentrations in lung interstitial fluid were 66% of corresponding plasma values within the first 240 min, and exceeded minimal inhibitory concentrations of most relevant bacteria. The experimental procedure was well tolerated by the patients and no adverse events were observed. The present study provides evidence for the first time that closed chest microdialysis of the human lung is a feasible and safe method to measure lung concentrations in patients in vivo. The present data also corroborate the use of cefpirome as a valuable agent in the treatment of lung infections with most extracellular bacteria.Keywords
This publication has 31 references indexed in Scilit:
- Impaired target site penetration of β -lactams may account for therapeutic failure in patients with septic shockCritical Care Medicine, 2001
- Austrian National Survey of Prevalence of Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae 1994-96Scandinavian Journal of Infectious Diseases, 1998
- Community-Acquired PneumoniaNew England Journal of Medicine, 1995
- The Importance of Pharmacokinetic/Pharmacodynamic Surrogate Markers to OutcomeClinical Pharmacokinetics, 1995
- Cefpirome Clinical PharmacokineticsClinical Pharmacokinetics, 1993
- The penetration of cefpirome into the potential sites of pulmonary infectionJournal of Antimicrobial Chemotherapy, 1991
- Drug distribution studies with microdialysis III: Extracellular concentration of caffeine in adipose tissue in manLife Sciences, 1991
- The antimicrobial activity of cefpirome, a new cephalosporinJournal of Antimicrobial Chemotherapy, 1985
- Assessment of Drug Disposition in the LungDrugs, 1984
- Penetration of Antibiotics into Respiratory SecretionsClinical Infectious Diseases, 1981